☰

Peyman Kabolizadeh, Ph.D. - Publications

Affiliations: 
2007 Virginia Commonwealth University, Richmond, VA, United States 
Area:
Inorganic Chemistry, Biochemistry, Oncology
Tree Info Similar researchers PubMed Report error

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Silva H, Frézard F, Peterson EJ, Kabolizadeh P, Ryan JJ, Farrell NP. Heparan sulfate proteoglycan-mediated entry pathway for charged tri-platinum compounds: differential cellular accumulation mechanisms for platinum. Molecular Pharmaceutics. 9: 1795-802. PMID 22494465 DOI: 10.1021/Mp300098T  0.616
2012 Kabolizadeh P, Engelmann BJ, Pullen N, Stewart JK, Ryan JJ, Farrell NP. Platinum anticancer agents and antidepressants: desipramine enhances platinum-based cytotoxicity in human colon cancer cells. Journal of Biological Inorganic Chemistry : Jbic : a Publication of the Society of Biological Inorganic Chemistry. 17: 123-32. PMID 21918844 DOI: 10.1007/S00775-011-0836-1  0.588
2011 Benedetti BT, Peterson EJ, Kabolizadeh P, Martínez A, Kipping R, Farrell NP. Effects of noncovalent platinum drug-protein interactions on drug efficacy: use of fluorescent conjugates as probes for drug metabolism. Molecular Pharmaceutics. 8: 940-8. PMID 21548575 DOI: 10.1021/Mp2000583  0.582
2010 Kabolizadeh P, Kipping R, Menon V, Ryan J, Peterson E, Povirk L, Farrell N. Abstract 2494: A non-covalent binding platinum drug, TriplatinNC, induces a G1 phase cell cycle arrest and p53-independent mechanisms of apoptosis Cancer Research. 70: 2494-2494. DOI: 10.1158/1538-7445.Am10-2494  0.739
2007 Mitchell C, Kabolizadeh P, Ryan J, Roberts JD, Yacoub A, Curiel DT, Fisher PB, Hagan MP, Farrell NP, Grant S, Dent P. Low-dose BBR3610 toxicity in colon cancer cells is p53-independent and enhanced by inhibition of epidermal growth factor receptor (ERBB1)-phosphatidyl inositol 3 kinase signaling. Molecular Pharmacology. 72: 704-14. PMID 17578896 DOI: 10.1124/Mol.107.038406  0.595
2007 Kabolizadeh P, Ryan J, Farrell N. Differences in the cellular response and signaling pathways of cisplatin and BBR3464 ([[trans-PtCl(NH3)(2)]2mu-(trans-Pt(NH3)(2)(H2N(CH2)(6)-NH2)2)]4+) influenced by copper homeostasis. Biochemical Pharmacology. 73: 1270-9. PMID 17234160 DOI: 10.1016/J.Bcp.2006.12.016  0.697
2004 Qu Y, Harris A, Hegmans A, Petz A, Kabolizadeh P, Penazova H, Farrell N. Synthesis and DNA conformational changes of non-covalent polynuclear platinum complexes. Journal of Inorganic Biochemistry. 98: 1591-8. PMID 15458821 DOI: 10.1016/J.Jinorgbio.2004.07.012  0.55
Show low-probability matches.